TY - JOUR AU - Yang, J. C. AU - Rosenberg, S. A. PY - 1988 DA - 1988// TI - Current approaches to the adoptive immunotherapy of cancer JO - Adv Exp Med Biol VL - 233 UR - https://doi.org/10.1007/978-1-4899-5037-6_50 DO - 10.1007/978-1-4899-5037-6_50 ID - Yang1988 ER - TY - JOUR AU - Draper, L. M. AU - Kwong, M. L. AU - Gros, A. AU - Stevanovic, S. AU - Tran, E. AU - Kerkar, S. PY - 2015 DA - 2015// TI - Targeting of HPV-16+ epithelial cancer cells by TCR gene engineered T cells directed against E6 JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-3341 DO - 10.1158/1078-0432.CCR-14-3341 ID - Draper2015 ER - TY - JOUR AU - June, C. H. AU - Sadelain, M. PY - 2018 DA - 2018// TI - Chimeric antigen receptor therapy JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMra1706169 DO - 10.1056/NEJMra1706169 ID - June2018 ER - TY - JOUR AU - Atilla, E. AU - Kilic, P. AU - Gurman, G. PY - 2018 DA - 2018// TI - Cellular therapies: day by day, all the way JO - Transfus Apher Sci. VL - 57 UR - https://doi.org/10.1016/j.transci.2018.04.019 DO - 10.1016/j.transci.2018.04.019 ID - Atilla2018 ER - TY - JOUR AU - Popovic, A. AU - Jaffee, E. M. AU - Zaidi, N. PY - 2018 DA - 2018// TI - Emerging strategies for combination checkpoint modulators in cancer immunotherapy JO - J Clin Invest. VL - 128 UR - https://doi.org/10.1172/JCI120775 DO - 10.1172/JCI120775 ID - Popovic2018 ER - TY - JOUR AU - Green, D. S. AU - Nunes, A. T. AU - Annunziata, C. M. AU - Zoon, K. C. PY - 2016 DA - 2016// TI - Monocyte and interferon based therapy for the treatment of ovarian cancer JO - Cytokine Growth Factor Rev VL - 29 UR - https://doi.org/10.1016/j.cytogfr.2016.02.006 DO - 10.1016/j.cytogfr.2016.02.006 ID - Green2016 ER - TY - JOUR AU - Liu, Y. AU - Zeng, G. PY - 2012 DA - 2012// TI - Cancer and innate immune system interactions: translational potentials for cancer immunotherapy JO - J Immunother VL - 35 UR - https://doi.org/10.1097/CJI.0b013e3182518e83 DO - 10.1097/CJI.0b013e3182518e83 ID - Liu2012 ER - TY - JOUR AU - Nakashima, H. AU - Miyake, K. AU - Clark, C. R. AU - Bekisz, J. AU - Finbloom, J. AU - Husain, S. R. PY - 2012 DA - 2012// TI - Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1152-x DO - 10.1007/s00262-011-1152-x ID - Nakashima2012 ER - TY - JOUR AU - Griffith, T. S. AU - Wiley, S. R. AU - Kubin, M. Z. AU - Sedger, L. M. AU - Maliszewski, C. R. AU - Fanger, N. A. PY - 1999 DA - 1999// TI - Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL JO - J Exp Med. VL - 189 UR - https://doi.org/10.1084/jem.189.8.1343 DO - 10.1084/jem.189.8.1343 ID - Griffith1999 ER - TY - JOUR AU - Mantovani, A. AU - Sozzani, S. AU - Locati, M. AU - Allavena, P. AU - Sica, A. PY - 2002 DA - 2002// TI - Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes JO - Trends Immunol VL - 23 UR - https://doi.org/10.1016/S1471-4906(02)02302-5 DO - 10.1016/S1471-4906(02)02302-5 ID - Mantovani2002 ER - TY - JOUR AU - Martinez, F. O. AU - Gordon, S. PY - 2014 DA - 2014// TI - The M1 and M2 paradigm of macrophage activation: time for reassessment JO - F1000Prime Rep. VL - 6 UR - https://doi.org/10.12703/P6-13 DO - 10.12703/P6-13 ID - Martinez2014 ER - TY - JOUR AU - Wang, N. AU - Liang, H. AU - Zen, K. PY - 2014 DA - 2014// TI - Molecular mechanisms that influence the macrophage m1–m2 polarization balance JO - Front Immunol. VL - 5 ID - Wang2014 ER - TY - JOUR AU - Lan, C. AU - Huang, X. AU - Lin, S. AU - Huang, H. AU - Cai, Q. AU - Wan, T. PY - 2013 DA - 2013// TI - Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer JO - Technol Cancer Res Treat. VL - 12 UR - https://doi.org/10.7785/tcrt.2012.500312 DO - 10.7785/tcrt.2012.500312 ID - Lan2013 ER - TY - JOUR AU - Johnson, C. L. AU - Green, D. S. AU - Zoon, K. C. PY - 2015 DA - 2015// TI - Human monocytes in the presence of interferons alpha2a and gamma are potent killers of serous ovarian cancer cell lines in combination with paclitaxel and carboplatin JO - J Interferon Cytokine Res VL - 35 UR - https://doi.org/10.1089/jir.2014.0057 DO - 10.1089/jir.2014.0057 ID - Johnson2015 ER - TY - JOUR AU - Green, D. S. AU - Nunes, A. T. AU - David-Ocampo, V. AU - Ekwede, I. B. AU - Houston, N. D. AU - Highfill, S. L. PY - 2018 DA - 2018// TI - A phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron((R)) (Peginterferon alfa-2b) and Actimmune((R)) (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer JO - J Transl Med. VL - 16 UR - https://doi.org/10.1186/s12967-018-1569-5 DO - 10.1186/s12967-018-1569-5 ID - Green2018 ER - TY - JOUR AU - Strasser, E. F. AU - Eckstein, R. PY - 2010 DA - 2010// TI - Optimization of leukocyte collection and monocyte isolation for dendritic cell culture JO - Transfus Med Rev VL - 24 UR - https://doi.org/10.1016/j.tmrv.2009.11.004 DO - 10.1016/j.tmrv.2009.11.004 ID - Strasser2010 ER - TY - STD TI - Human cells, tissues, and cellular and tissue-based products. Code of Federal Regulations, Title 21, Part 1271.90 (a)(1), 2018. ID - ref17 ER - TY - JOUR AU - Faradji, A. AU - Bohbot, A. AU - Schmitt-Goguel, M. AU - Dumont, S. AU - Eischen, A. AU - Wiesel, M. L. PY - 1991 DA - 1991// TI - Apheresis-elutriation program for adoptive immunotherapy with autologous activated monocytes in cancer patients JO - Int J Artif Organs VL - 14 UR - https://doi.org/10.1177/039139889101400511 DO - 10.1177/039139889101400511 ID - Faradji1991 ER - TY - JOUR AU - Allavena, P. AU - Peccatori, F. AU - Maggioni, D. AU - Erroi, A. AU - Sironi, M. AU - Colombo, N. PY - 1990 DA - 1990// TI - Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells JO - Cancer Res VL - 50 ID - Allavena1990 ER - TY - JOUR AU - Berek, J. S. AU - Hacker, N. F. AU - Lichtenstein, A. AU - Jung, T. AU - Spina, C. AU - Knox, R. M. PY - 1985 DA - 1985// TI - Intraperitoneal recombinant alpha-interferon for “salvage” immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study JO - Cancer Res VL - 45 ID - Berek1985 ER - TY - JOUR AU - Colombo, N. AU - Peccatori, F. AU - Paganin, C. AU - Bini, S. AU - Brandely, M. AU - Mangioni, C. PY - 1992 DA - 1992// TI - Anti-tumor and immunomodulatory activity of intraperitoneal IFN-gamma in ovarian carcinoma patients with minimal residual tumor after chemotherapy JO - Int J Cancer VL - 51 UR - https://doi.org/10.1002/ijc.2910510109 DO - 10.1002/ijc.2910510109 ID - Colombo1992 ER - TY - JOUR AU - D’Acquisto, R. AU - Markman, M. AU - Hakes, T. AU - Rubin, S. AU - Hoskins, W. AU - Lewis, J. L. PY - 1988 DA - 1988// TI - A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma JO - J Clin Oncol VL - 6 UR - https://doi.org/10.1200/JCO.1988.6.4.689 DO - 10.1200/JCO.1988.6.4.689 ID - D’Acquisto1988 ER - TY - JOUR AU - Iaffaioli, R. V. AU - Frasci, G. AU - Facchini, G. AU - Pagliarulo, C. AU - Pacelli, R. AU - Scala, S. PY - 1991 DA - 1991// TI - Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer, preliminary data JO - Eur J Gynaecol Oncol. VL - 12 ID - Iaffaioli1991 ER - TY - JOUR AU - Pujade-Lauraine, E. AU - Guastalla, J. P. AU - Colombo, N. AU - Devillier, P. AU - Francois, E. AU - Fumoleau, P. PY - 1996 DA - 1996// TI - Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy JO - J Clin Oncol VL - 14 UR - https://doi.org/10.1200/JCO.1996.14.2.343 DO - 10.1200/JCO.1996.14.2.343 ID - Pujade-Lauraine1996 ER - TY - JOUR AU - Willemse, P. H. AU - Vries, E. G. AU - Mulder, N. H. AU - Aalders, J. G. AU - Bouma, J. AU - Sleijfer, D. T. PY - 1990 DA - 1990// TI - Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer JO - Eur J Cancer VL - 26 UR - https://doi.org/10.1016/0277-5379(90)90233-J DO - 10.1016/0277-5379(90)90233-J ID - Willemse1990 ER - TY - JOUR AU - Andreesen, R. AU - Scheibenbogen, C. AU - Brugger, W. AU - Krause, S. AU - Meerpohl, H. G. AU - Leser, H. G. PY - 1990 DA - 1990// TI - Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy JO - Cancer Res VL - 50 ID - Andreesen1990 ER - TY - JOUR AU - Faradji, A. AU - Bohbot, A. AU - Frost, H. AU - Schmitt-Goguel, M. AU - Siffert, J. C. AU - Dufour, P. PY - 1991 DA - 1991// TI - Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis JO - J Clin Oncol VL - 9 UR - https://doi.org/10.1200/JCO.1991.9.7.1251 DO - 10.1200/JCO.1991.9.7.1251 ID - Faradji1991 ER - TY - JOUR AU - Stevenson, H. C. AU - Keenan, A. M. AU - Woodhouse, C. AU - Ottow, R. T. AU - Miller, P. AU - Steller, E. P. PY - 1987 DA - 1987// TI - Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis JO - Cancer Res VL - 47 ID - Stevenson1987 ER -